drugset / Trial / NCT00322907
Cotrifazid Safety and Efficacy Against Malaria
Phase 2
Terminated
330 enrolled
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
Papua New Guinea Institute of Medical Research · collabSwiss Tropical & Public Health Institute · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study was to assess the safety and efficacy of Cotrifazid to treat uncomplicated resistant malaria and to compare the outcome with mefloquine or quinine+sulfadoxine/pyrimethamine (SP)
Timeline
- Start
- 2000-04
- Primary completion
- —
- Completion
- 2003-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cotrifazid | Unknown | — | — |
| Subject | Mefloquine | Unknown | — | — |
| Subject | Quinine | Small molecule | — | — |
| Subject | pyrimethamine | Small molecule | — | — |
| Subject | sulfadoxine | Small molecule | — | — |